James Michael Randall

Title(s)Assistant Clinical Professor, Medicine
SchoolHealth Sciences
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Society of Clinical Oncology (ASCO)2011Conquer Cancer Foundation Merit Award
    University of Alabama School of Medicine2005Sarah F. Davis Award best all-around male medical student

    Collapse Overview 
    Collapse Overview
    Research Interests
    Dr. Randall has recently joined the division, and is building a clinical research program focused on urologic cancer. He is also interested in interventions that may identify and help patients with forms of cancer-related distress, including depression and suicidal ideation.

    Education and Training
    MD - University of Alabama, School of Medicine, Birmingham, AL - 2005
    Internship & Residency - UC San Diego, School of Medicine, San Diego, CA - 2005-2008
    Fellowship, Hematology/Oncology - UC San Diego, School of Medicine, San Diego, CA - 2009-2012

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Khagi Y, Goodman AM, Daniels GA, Patel SP, Sacco AG, Randall JM, Bazhenova LA, Kurzrock R. Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy. Clin Cancer Res. 2017 Oct 01; 23(19):5729-5736. PMID: 28972084.
      View in: PubMed
    2. Hamilton Z, Lee HJ, Jimenez J, Lane BR, Wang S, Beksac AT, Gillis K, Alagh A, Tobert C, Randall JM, Kane CJ, Millard F, Campbell SC, Derweesh IH. Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma. BJU Int. 2016 Dec; 118(6):927-934. PMID: 27008916.
      View in: PubMed
    3. Randall JM, Millard F, Kurzrock R. Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art. Cancer Metastasis Rev. 2014 Dec; 33(4):1109-24. PMID: 25365943.
      View in: PubMed
    4. Randall JM, Voth R, Burnett E, Bazhenova L, Bardwell WA. Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: a pilot study. Support Care Cancer. 2013 May; 21(5):1503-7. PMID: 23325092.
      View in: PubMed